CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 
 
 
Ctd Holdings Inc  (CTDH)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
 
   Industry Biotechnology & Drugs
   Sector  Healthcare
 
Price: $0.5500 $0.00 0.000%
Day's High: $ 0.55 Week Perf: 0.00
Day's Low: $ 0.53 30 Day Perf: 25 %
Volume (M): 2 52 Wk High: $ 0.64
Volume (M$): $ 1 52 Wk Avg: $ 0.38
Open: $ 0.55 52 Wk Low: 0.25
You need to upgrade your Flash Player


 Market Capitalization (Millions $) 43
 Shares Outstanding (Millions) 79
 Employees 6
 Revenues (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -4
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0
Ctd Holdings Inc

We are a biotechnology company that develops cyclodextrin-based products for the treatment of disease. We filed a Type II Drug Master File with the U.S. Food and Drug Administration (“FDA”) in 2014 for our lead drug candidate, Trappsol® Cyclo™ (hydroxypropyl beta cyclodextrin) as a treatment for Neimann-Pick Type C disease (“NPC”). NPC is a rare and fatal cholesterol metabolism disease found primarily in children and young adults. In 2015, we launched an International Clinical Program for Trappsol® Cyclo™ as a treatment for NPC. In 2016, we filed an Investigational New Drug application (“IND”) with the FDA, which describes our Phase I clinical plans for a randomized, double blind, parallel group study at a single clinical site in the US. The IND was approved by the FDA in September 2016, and in January 2017 the FDA granted Fast Track designation to Trappsol® Cyclo™ for the treatment of NPC. We have also filed Clinical Trial Applications with several European regulators, including the United Kingdom's Medicines and Healthcare Products Regulatory Agency, which approved our application. We expect to commence a U.S. clinical study in 2017 in which we will provide Trappsol® Cyclo™ intravenously to NPC patients two years of age and older in order to track biochemical markers of cholesterol metabolism and to measure effects on neurologic, lung and liver symptoms, with similar studies to be conducted in Europe.



CTDH is expected to report next financial results on November 09, 2018.
 
  Company Estimates
  Revenue Outlook
Ctd Holdings Inc does not provide revenue guidance.

Earnings Outlook
Ctd Holdings Inc does not provide earnings estimates.

Geographic Revenue Dispersion

Everest Reinsurance Holdings Inc

Everest Reinsurance Holdings Inc announced second quarter operating deficit of $-305.184 millions

In the second quarter Everest Reinsurance Holdings Inc eps of $1.70 per share compare to $0.00 a year ago and eps dropped by -66.73 % from $5.11 per share from the previous quarter.

Sales increased sharply by 180.79 % to $1.29 billions from $458.46 millions in the same quarter a year ago and sequentially Sales improved by 22.5 % from $1.05 billions.

Broadvision Inc

Broadvision Inc announced second quarter operating loss of $-1.845 millions

Declining demand caused increase in losses for the second quarter, company's loss per share grew to $-0.43 from $-0.48 where Sales fell by -23.03 % to $1.24 millions from $1.62 millions a year ago.

Ark Restaurants Corp

Ark Restaurants Corp announced third quarter operating income of $3.786 millions

Company displayed pleasant results in the third quarter. Sales were at $44.80 millions higher by 16.69 % year on year and advanced by 13.84 % quarter on quarter, while earnings jumped by 53.06 % to $0.75, sequentially eps soared by 63.04 %.

American Church Mortgage Company

American Church Mortgage Company announced second quarter operating deficit of $-0.076312 millions

American Church Mortgage Company reported disastrous second quarter, where Sales faded by -73.28 % to $0.19 millions and loss per share has widen at $-0.05, from the same quarter a year ago.

Capstone Companies, Inc.

Capstone Companies, Inc announced second quarter operating deficit of $-0.557918 millions

Capstone Companies, Inc reported disastrous second quarter, where Sales faded by -79.42 % to $2.10 millions and loss per share has widen at $-0.01, from the same quarter a year ago.




CTDH's Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 71.37
Price to Sales (Expected) -
Price to Book 43.22
PEG (TTM) -
CTDH's Financial Strength Current
Quick Ratio 1.2
Working Capital Ratio 1.65
Leverage Ratio (MRQ) 1.28
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -
Per Share Current
Earnings (TTM) -0.06 $
Revenues (TTM) 0.01 $
Cash Flow (TTM) 0 $
Cash 0.02 $
Book Value 0.01 $
Dividend (TTM) 0 $

• View Valuation Comparisons • View Growth Rates Comparisons

You need to upgrade your Flash Player
CTDH's Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -686,665
Receivable Turnover Ratio (TTM) -
Inventory Turnover Ratio (TTM) 0.28
Asset Turnover Ratio (TTM) -
CTDH's Profitability Ratio Current
Gross Margin -
Operating Margin -
Net Margin -
Net Cash Flow Margin -
Effective Tax Rate (TTM) -
Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Payout Ratio (TTM) -
• View Efficiency Comparisons • View Profitability Comparisons • View Management Effectiveness


You need to upgrade your Flash Player

   
You need to upgrade your Flash Player
Major Competitors Stock performance

5 Days Decrease / Increase
     
• View Complete Report
   


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

GTII's Profile

Stock Price

GTII's Financials

Business Description

Fundamentals

Charts & Quotes

GTII's News

Suppliers

GTII's Competitors

Customers & Markets

Economic Indicators

GTII's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071